Companies /Healthcare

Palatin Technologies Inc

NYSE ARCA: PTN Biotechnology

$4.82

▼ $0.29 (−5.68%) today

Markets closed · 7:08pm ET

PTN at a Glance

Valuation

Market cap: $9.1M

Profitability

Revenue (TTM): $13.2M
Profit margin: -63.5%
EPS (TTM): $-2.96

Price

52-week range: $5 – $31
Street target: $53.50

Earnings

Next report: Nov 13, 2026

Headquartered in Princeton, NJ Fiscal year ends June NYSE ARCA: PTN palatin.com

About Palatin Technologies

Palatin Technologies, Inc., a specialty biopharmaceutical company, develops targeted receptor-specific therapies for the treatment of various diseases in the United States. The company is headquartered in Cranbury, New Jersey.

PTN Coverage

8:15am ET

Investing

Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More

Pre-Market Stock Futures: Futures are trading lower on Wednesday after an ADP report showing job losses, following a stellar day across Wall Street on Tuesday. All of the major indices finished the…

ACHC AEO BHVN

Lee Jackson

Frequently Asked Questions

What does Palatin Technologies do?

What is the PTN stock price target?

The Wall Street consensus 12-month price target for PTN is $53.50.